David N. Whittern

1.2k total citations
29 papers, 915 citations indexed

About

David N. Whittern is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, David N. Whittern has authored 29 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Organic Chemistry and 11 papers in Molecular Biology. Recurrent topics in David N. Whittern's work include Microbial Natural Products and Biosynthesis (10 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and Biological Activity (4 papers). David N. Whittern is often cited by papers focused on Microbial Natural Products and Biosynthesis (10 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and Biological Activity (4 papers). David N. Whittern collaborates with scholars based in United Kingdom, United States and Poland. David N. Whittern's co-authors include James B. McAlpine, Jill E. Hochlowski, Alex Buko, Stephen G. Spanton, Alexander M. Buko, Nicholas C. Carpita, Rodger F. Henry, Geewananda P. Gunawardana, Ronald R. Rasmussen and Irini Akritopoulou‐Zanze and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

David N. Whittern

28 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David N. Whittern United Kingdom 17 469 364 289 101 79 29 915
Daniel Hunziker Switzerland 13 450 1.0× 411 1.1× 239 0.8× 68 0.7× 83 1.1× 19 1.1k
Robert Southgate United Kingdom 17 731 1.6× 510 1.4× 280 1.0× 49 0.5× 71 0.9× 75 1.2k
A.K. Ganguly United States 20 605 1.3× 399 1.1× 227 0.8× 34 0.3× 52 0.7× 86 1.1k
Ferenc Sztaricskai Hungary 20 726 1.5× 532 1.5× 212 0.7× 128 1.3× 51 0.6× 102 1.2k
Ze‐Qi Xu United States 20 732 1.6× 490 1.3× 229 0.8× 242 2.4× 81 1.0× 50 1.4k
Gregory S. Basarab United States 23 432 0.9× 835 2.3× 211 0.7× 109 1.1× 88 1.1× 61 1.4k
Masami Ohtsuka Japan 17 550 1.2× 325 0.9× 209 0.7× 53 0.5× 81 1.0× 27 945
KYOICHIRO SAITOH Germany 16 743 1.6× 478 1.3× 371 1.3× 94 0.9× 60 0.8× 21 1.2k
NOBUYOSHI SHIMADA Japan 17 515 1.1× 408 1.1× 220 0.8× 143 1.4× 35 0.4× 26 911
Stephen W. Elson United States 18 181 0.4× 554 1.5× 405 1.4× 57 0.6× 47 0.6× 40 931

Countries citing papers authored by David N. Whittern

Since Specialization
Citations

This map shows the geographic impact of David N. Whittern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Whittern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Whittern more than expected).

Fields of papers citing papers by David N. Whittern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Whittern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Whittern. The network helps show where David N. Whittern may publish in the future.

Co-authorship network of co-authors of David N. Whittern

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Whittern. A scholar is included among the top collaborators of David N. Whittern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Whittern. David N. Whittern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spanton, Stephen G. & David N. Whittern. (2009). The development of an NMR chemical shift prediction application with the accuracy necessary to grade proton NMR spectra for identity. Magnetic Resonance in Chemistry. 47(12). 1055–1061. 16 indexed citations
2.
Judd, Andrew S., et al.. (2007). Concise Construction of Novel Bridged Bicyclic Lactams by Sequenced Ugi/RCM/Heck Reactions. Organic Letters. 9(24). 5119–5122. 82 indexed citations
3.
Kumar, Gondi, Ronald Lee, David N. Whittern, et al.. (1999). In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification. Drug Metabolism and Disposition. 27(1). 86–91. 51 indexed citations
4.
Hochlowski, Jill E., et al.. (1999). Applications of Raman spectroscopy to combinatorial chemistry. Drugs of the Future. 24(5). 539–539. 11 indexed citations
5.
Hill, David R., et al.. (1996). Novel macrolides via meso-tetraarylmetalloporphyrin assisted oxidations. Tetrahedron Letters. 37(6). 787–790. 4 indexed citations
6.
Hochlowski, Jill E., et al.. (1994). Aselacins, novel compounds that inhibit binding of endothelin to its receptor. II. Isolation and elucidation of structures.. The Journal of Antibiotics. 47(5). 528–535. 15 indexed citations
7.
Rasmussen, Ronald R., et al.. (1993). Calbistrins, novel antifungal agents produced by Penicillium restrictum. II. Isolation and elucidation of structure.. The Journal of Antibiotics. 46(1). 39–47. 23 indexed citations
8.
9.
JARVIS, B. B., et al.. (1992). New Trichoverroids from Myrothecium verrucaria Isolated by High Speed Countercurrent Chromatography. Journal of Natural Products. 55(10). 1441–1446. 12 indexed citations
10.
Hochlowski, Jill E., et al.. (1991). Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures.. The Journal of Antibiotics. 44(12). 1318–1330. 21 indexed citations
11.
Dellaria, Joseph F., Robert G. Maki, Herman H. Stein, et al.. (1990). New inhibitors of renin that contain novel phosphostatine Leu-Val replacements. Journal of Medicinal Chemistry. 33(2). 534–542. 96 indexed citations
12.
Tadanier, Jack, et al.. (1990). Synthesis of some C-8-modified 3-deoxy-β-d-manno-2-octulosonic acid analogs as inhibitors of CMP-Kdo synthetase. Carbohydrate Research. 201(2). 185–207. 9 indexed citations
13.
McAlpine, James B., et al.. (1990). Altromycins, novel pluramycin-like antibiotics. II. Isolation and elucidation of structure.. The Journal of Antibiotics. 43(3). 229–237. 28 indexed citations
14.
Whittern, David N., et al.. (1989). Coumamidines, new broad spectrum antibiotics of the cinodine type. II. Isolation and structural elucidation.. The Journal of Antibiotics. 42(4). 533–537. 8 indexed citations
15.
Buko, Alexander M., et al.. (1989). Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation.. The Journal of Antibiotics. 42(4). 512–520. 80 indexed citations
16.
McAlpine, James B., et al.. (1988). Tirandalydigin, a novel tetramic acid of the tirandamycin-streptolydigin type. II. Isolation and structural characterization.. The Journal of Antibiotics. 41(1). 36–44. 21 indexed citations
17.
Hochlowski, Jill E., et al.. (1988). Phenelfamycins, a novel complex of elfamycin-type antibiotics. II. Isolation and structure determination.. The Journal of Antibiotics. 41(10). 1300–1315. 23 indexed citations
18.
Rasmussen, Ronald R., et al.. (1987). Coloradocin, an antibiotic from a new Actinoplanes. II. Identity with luminamicin and elucidation of structure.. The Journal of Antibiotics. 40(10). 1383–1393. 23 indexed citations
19.
Carpita, Nicholas C. & David N. Whittern. (1986). A highly substituted glucuronoarabinoxylan from developing maize coleoptiles. Carbohydrate Research. 146(1). 129–140. 39 indexed citations
20.
Taylor, Stephen K., et al.. (1983). A comparison of some friedel‐crafts and grignard reactions of optically active phenyloxirane. Journal of Heterocyclic Chemistry. 20(6). 1745–1747. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Hunziker Breakdown of academic impact, for papers by Robert Southgate Breakdown of academic impact, for papers by A.K. Ganguly Breakdown of academic impact, for papers by Ferenc Sztaricskai Breakdown of academic impact, for papers by Ze‐Qi Xu Breakdown of academic impact, for papers by Gregory S. Basarab Breakdown of academic impact, for papers by Masami Ohtsuka Breakdown of academic impact, for papers by KYOICHIRO SAITOH Breakdown of academic impact, for papers by NOBUYOSHI SHIMADA Breakdown of academic impact, for papers by Stephen W. Elson
Rankless by CCL
2026